| A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed (NCT05422326) | Seqirus | 2022-07-18 |
| Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD) (NCT05606198) | Technische Universität Dresden | 2022-05-01 |
| STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care (NCT05277285) | Hellenic Institute for the Study of Sepsis | 2022-04-01 |
| Tobacco Use and the Risk of COVID-19 and Adverse Outcomes (NCT05321433) | Karolinska Institutet | 2022-04-01 |
| Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory (NCT05376124) | First Affiliated Hospital Xi'an Jiaotong University | 2022-01-01 |
| Post-COVID-19 Monitoring in Routine Health Insurance Data (NCT05074953) | Technische Universität Dresden | 2021-08-01 |
| Universal Anti-Viral Vaccine for Healthy Elderly Adults (NCT04441047) | Mirror Biologics, Inc. | 2021-07-12 |
| EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 (NCT04822818) | Assistance Publique - Hôpitaux de Paris | 2021-04-17 |
| Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) (NCT04710199) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2021-02-23 |
| A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults (NCT04758962) | GlaxoSmithKline | 2021-02-15 |
| Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes (NCT04769167) | Washington University School of Medicine | 2021-02-01 |
| A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety (NCT04644484) | Synermore Biologics (Suzhou) Co., Ltd. | 2020-09-23 |
| Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 (NCT04476979) | Assistance Publique - Hôpitaux de Paris | 2020-07-16 |
| Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) (NCT04382131) | University of Edinburgh | 2020-06-23 |
| Bacillus Calmette-guérin Vaccination to Prevent COVID-19 (NCT04414267) | Hellenic Institute for the Study of Sepsis | 2020-05-26 |
| Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 (NCT04412551) | Dalarna County Council, Sweden | 2020-05-20 |
| SARS-CoV 2 in Personal Protective Equipment (NCT04398043) | Hospital de Clinicas José de San Martín | 2020-05-15 |
| Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early (NCT04398004) | Hellenic Institute for the Study of Sepsis | 2020-05-06 |
| ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 (NCT04367740) | University of North Carolina, Chapel Hill | 2020-04-28 |
| CoVid-19 - Infection and Antibody Formation in the Viennese Population (NCT04346264) | Ludwig Boltzmann Institute for Lung Health | 2020-04-27 |
| A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults (NCT04380701) | BioNTech SE | 2020-04-23 |
| Convalescent Plasma Collection and Treatment in Pediatrics and Adults (NCT04376034) | West Virginia University | 2020-04-16 |
| suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) (NCT04357366) | Hellenic Institute for the Study of Sepsis | 2020-04-15 |
| Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 (NCT04322396) | Chronic Obstructive Pulmonary Disease Trial Network, Denmark | 2020-04-06 |
| Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction (NCT04339712) | Hellenic Institute for the Study of Sepsis | 2020-04-02 |
| LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System (NCT04633603) | University of Pecs | 2020-01-15 |
| Modelling the Interaction Between Synthetic Model Immunogens and the Induced B and T Cell Repertoires. (NCT04046978) | Imperial College London | 2019-12-11 |
| Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects (NCT04074928) | Seqirus | 2019-09-06 |
| A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults (NCT04062669) | GlaxoSmithKline | 2019-08-13 |
| Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198) | Christian von Buchwald | 2019-03-01 |
| The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure (NCT03640728) | First Affiliated Hospital Xi'an Jiaotong University | 2019-01-25 |
| Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly (NCT03739112) | Medicago | 2018-09-18 |
| Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine (NCT03776994) | SRI International | 2018-07-17 |
| Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (NCT03392207) | Butantan Institute | 2018-04-23 |
| Cantharidin and Occlusion in Verruca Epithelium (NCT03487549) | Verrica Pharmaceuticals Inc. | 2018-03-27 |
| A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children (NCT03192371) | GlaxoSmithKline | 2018-02-15 |
| The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine (NCT03294135) | GlaxoSmithKline | 2017-10-05 |
| Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults (NCT03301051) | Medicago | 2017-08-31 |
| VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (NCT03110770) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-29 |
| Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza (NCT02927431) | GlaxoSmithKline | 2017-01-19 |
| A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children (NCT02991872) | GlaxoSmithKline | 2016-12-16 |
| Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults (NCT02831751) | Medicago | 2016-04-01 |
| Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults (NCT02768805) | Medicago | 2016-03-02 |
| Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) (NCT02613403) | Merck Sharp & Dohme LLC | 2015-12-10 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection (NCT02593851) | Janssen Sciences Ireland UC | 2015-12-04 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children (NCT02548078) | GlaxoSmithKline | 2015-11-09 |
| A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis. (NCT02545517) | GlaxoSmithKline | 2015-10-05 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults (NCT02485301) | GlaxoSmithKline | 2015-07-15 |
| Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza (NCT02469298) | GlaxoSmithKline | 2015-06-01 |
| Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection (NCT03119025) | Russian Academy of Medical Sciences | 2015-05-01 |
| Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults (NCT02233816) | Medicago | 2014-07-28 |
| Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population (NCT02236052) | Medicago | 2014-07-16 |
| Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA (NCT02012998) | Sanofi Pasteur, a Sanofi Company | 2014-01-01 |
| Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. (NCT02022163) | Medicago | 2013-12-01 |
| Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults (NCT01991587) | Medicago | 2013-10-08 |
| Replacement of Lamivudine by Telbivudine to Improve Renal Function (NCT02447705) | Chang Gung Memorial Hospital | 2013-06-01 |
| Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. (NCT01991561) | Medicago | 2013-06-01 |
| Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) (NCT01839188) | MCM Vaccines B.V. | 2013-05-01 |
| Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination (NCT01839175) | Sanofi Pasteur, a Sanofi Company | 2013-04-01 |
| DNA-based Influenza Vaccine in the Elderly (NCT01587131) | University of Manitoba | 2012-06-01 |
| Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) (NCT01553279) | MCM Vaccines B.V. | 2012-03-30 |
| Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules (NCT01562444) | GlaxoSmithKline | 2012-03-08 |
| Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) (NCT01480258) | MCM Vaccines B.V. | 2011-11-23 |
| Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant (NCT01289301) | Hannover Medical School | 2011-10-01 |
| Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) (NCT01341639) | MCM Vaccines B.V. | 2011-05-26 |
| A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) (NCT01340937) | Merck Sharp & Dohme LLC | 2011-05-10 |
| Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) (NCT01337167) | Merck Sharp & Dohme LLC | 2011-04-19 |
| Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru (NCT02630082) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine (NCT01244867) | Medicago | 2010-11-01 |
| Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients (NCT01062659) | University of Ulm | 2010-02-01 |
| Clinic-based ART Diagnostic Evaluation (NCT01791556) | Walter Reed Army Institute of Research (WRAIR) | 2010-01-26 |
| Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children (NCT01021397) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults (NCT00980447) | UMN Pharma Inc. | 2009-10-01 |
| Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients (NCT01055990) | Shanghai Public Health Clinical Center | 2009-10-01 |
| Safety of H1N1 Influenza Vaccination in Pregnant Women (NCT01842997) | Jiangsu Province Centers for Disease Control and Prevention | 2009-10-01 |
| Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults (NCT00984945) | Medicago | 2009-09-01 |
| Avian Influenza Studies In Lebanon (NCT01107262) | St. Jude Children's Research Hospital | 2009-07-01 |
| Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older (NCT00975572) | Jiangsu Province Centers for Disease Control and Prevention | 2009-07-01 |
| Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults (NCT00921726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-01 |
| Epidemiological Study in Children and Adolescents With Chronic Hepatitis B (NCT01163240) | Novartis Pharmaceuticals | 2009-06-01 |
| Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles (NCT00921934) | Pascoe Pharmazeutische Praeparate GmbH | 2009-04-01 |
| A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B (NCT00815464) | Yu Medical Garden | 2009-03-01 |
| A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen (NCT00749580) | University of South Florida | 2008-11-01 |
| Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine (NCT00734175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults (NCT00516035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-09-01 |
| Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults (NCT00488046) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-06-01 |
| Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations (NCT00448604) | University Hospital, Geneva | 2007-05-01 |
| Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults (NCT00366782) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-03-01 |
| Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B) (NCT00380237) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults (NCT00347672) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants (NCT00308412) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets (NCT00343278) | GlaxoSmithKline | 2005-07-01 |
| Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A) (NCT00110279) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination (NCT00219453) | PATH | 2004-10-01 |
| Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C (NCT00948220) | University of Ulm | 2003-07-01 |
| Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers (NCT00001164) | National Cancer Institute (NCI) | 1978-07-01 |
| Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine (NCT00722774) | National Institute of Allergy and Infectious Diseases (NIAID) | |